These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: In vivo androgen retention in mouse kidney.
    Author: Bullock LP, Bardin CW.
    Journal: Steroids; 1975 Jan; 25(1):107-19. PubMed ID: 1111170.
    Abstract:
    The in vivo retention of 3-H-testosterone, dihydrotestosterone (DHT), 3alpha-androstanediol (3alpha-DIOL), 3beta-DIOL, androstenedione, progesterone and cortisol by renal cytoplasm and nuclei of male and female mice was studied. Testosterone was the major androgen isolated from cytoplasm and nuclei following testosterone or androstenedione administration. By contrast, DHT was the major intracellular androgen after DHT, 3alpha- or 3beta-DIOL injection. The uptake of 3-H-testosterone or 3-H-DHT was abolished by excess unlabeled testosterone, DHT or cyproterone acetate. Androgen concentrations in kidney fractions from female mice were similar to those from males. There was no appreciable concentration of the isolated steroids following 3-H-progesterone administration. 3H-cortisol was concentrated in both cytoplasm and nuclei but was not displaced by non-radioactive androgens. These findings suggest that in contrast to prostate, mouse kidney can concentrate both testosterone and DHT. However, since testosterone is the major androgen in blood and since it is not metabolized in kidney, it is the major effector androgen in this organ. Androstenedione is active via conversion to testosterone while DIOLS are androgenic via metabolism to DHT.
    [Abstract] [Full Text] [Related] [New Search]